Wegovy 0.5 mg/0.5 ml Pen: Understanding This Dose Stage

Wegovy (semaglutide) is a once-weekly injectable medicine supplied as pre-filled pens in a range of strengths. According to the electronic Medicines Compendium, the dose stages commonly referenced are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg — each delivered in a pre-filled pen designed for subcutaneous injection. The 0.5 mg/0.5 ml pen sits at the second stage of this schedule.

How titration generally works

Treatment is typically started at a low dose to allow the body to adjust, then increased in steps over a period of months. The pace and endpoint of that titration is a decision made between you and your prescriber — it is not something to adjust independently. If you have questions about where you are in your schedule or whether a change is appropriate, your prescriber or doctor is the right person to ask.

It is worth knowing that some people stay at a particular dose stage for longer than the standard schedule if their prescriber judges that to be the right approach. Others may reach the 1.7 mg or 2.4 mg maintenance dose over time. For a broader look at the full range of Wegovy mg dose options, that page covers each strength in context.

A note on less common dose figures

You may occasionally see figures such as 1 mg/0.5 ml referenced — this simply reflects the concentration of the pen at that strength, not a different product. Similarly, queries around a "7.2 mg" strength refer to a dose that is not a currently available Wegovy pen strength; if you have seen this figure elsewhere, check with your prescriber or pharmacist for clarity. For information specifically on the Wegovy 1.7 mg dose stage, that page goes into more detail.

Wegovy and Mounjaro: different medicines

Wegovy (semaglutide) and Mounjaro (tirzepatide) are both once-weekly injectables used in weight management, but they are distinct medicines with different active substances and mechanisms. Semaglutide acts on GLP-1 receptors; tirzepatide acts on both GLP-1 and GIP receptors. There is no straightforward dose equivalence between them — any switch or comparison is a clinical decision for your prescriber. You can read more on the Mounjaro dosing overview if that is relevant to your situation.

If you are curious about real-world experiences at this dose stage, the page covering Wegovy 0.5 mg user experiences may be useful reading.

Keeping an accurate record of every dose you take is one of the most practical things you can do on a weekly injection schedule — and that is exactly where GLP Trackr starts. The app's dose logging feature lets you record each injection with the date, time, and dose strength, so you always have a clear, timestamped history to hand.

Beyond logging, GLP Trackr sends gentle dose reminders so a weekly injection is never accidentally missed or delayed. And if you do miss a dose, the app lets you note it so you can discuss the situation with your prescriber — the decision on what to do next always belongs with them, not with an app or a quick search online.

Over time, that logged history becomes a useful resource: a clear picture of your journey through each dose stage that you can bring to prescriber appointments. The doctor report feature compiles your data neatly so those conversations are better informed.

Any decision about your dose — including whether or when to move to the next strength — should be made with your prescriber. If you experience side effects that feel severe, persistent, or worrying at any stage, contact your healthcare professional promptly rather than adjusting your dose on your own. Side effects should also be reported to your national pharmacovigilance scheme (such as the UK Yellow Card scheme or your country's equivalent) and to your healthcare professional.

Ready to keep a proper record of your Wegovy journey? GLP Trackr is available free on the App Store and Google Play — give it a try with a 7-day free trial and see how straightforward dose tracking can be.